Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Terbutaline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 5/20 | 1.00 |
| ▸ | LMNA | P02545 | 5/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 4/20 | 1.00 |
| ▸ | TSHR | P16473 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | CASP7 | P55210 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.84 |
| ▸ | MEN1 | O00255 | 2/20 | 0.84 |
| ▸ | BLM | P54132 | 2/20 | 0.84 |
| ▸ | CASP1 | P29466 | 1/20 | 0.84 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.84 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.60 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.60 |
| ▸ | HTR1A | P08908 | 1/20 | 0.60 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.60 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.60 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.60 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Terbutaline SCHEMBL4391 | 1.00 | LMNA (1.00) | LMNAADRB2HIF1ATSHRKMT2A | |
| Terbutaline SCHEMBL13327959 | 1.00 | LMNA (1.00) | LMNAADRB2HIF1ATSHRKMT2A | |
| Terbutaline SCHEMBL404480 | 0.98 | ADRB2 (0.96) | LMNAADRB2HIF1ATSHRKMT2A | |
| Terbutaline SCHEMBL11703058 | 0.98 | ADRB2 (0.96) | LMNAADRB2HIF1ATSHRKMT2A | |
| Terbutaline SCHEMBL41870 | 0.92 | LMNA (1.00) | LMNAADRB2HIF1ATSHRKMT2A | |
| Terbutaline SCHEMBL9614480 | 0.92 | LMNA (1.00) | LMNAADRB2HIF1ATSHRKMT2A | |
| Terbutaline SCHEMBL28324621 | 0.92 | LMNA (0.84) | LMNAADRB2HIF1ATSHRKMT2A | |
| Terbutaline SCHEMBL26462 | 0.92 | LMNA (1.00) | LMNAADRB2HIF1ATSHRKMT2A | |
| Terbutaline SCHEMBL5178614 | 0.92 | LMNA (1.00) | LMNAADRB2HIF1ATSHRKMT2A | |
| Terbutaline SCHEMBL3937997 | 0.92 | LMNA (1.00) | LMNAADRB2HIF1ATSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11297 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6423298-B1 | — | — | None | — | — | US | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-4434588-B1 | AEROSOL DELIVERY DEVICE | PARI PHARMA GMBH (DE) | 2026-04-08 | — | — | EP | claimed |
| US-20260076872-A1 | POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME | SIO2 MEDICAL PRODUCTS LLC (US) | 2026-03-19 | — | — | US | claimed |
| US-20250242092-A1 | SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS | SIO2 MEDICAL PRODUCTS INC (US) | 2025-07-31 | — | — | US | claimed |
| CN-120114422-A | Atomized inhalation solution for treating bronchial asthma and preparation method and application thereof | 中南大学湘雅二医院 | 2025-06-10 | — | — | CN | claimed |
| CN-120078752-A | Particles for large-dose water-soluble medicine inhalation powder aerosol and preparation method thereof | 沈阳药科大学 | 2025-06-03 | — | — | CN | claimed |
| CN-119632957-B | Terbutaline sulfate solution for aerosol inhalation and preparation method thereof | 江苏长泰药业股份有限公司 | 2025-05-27 | — | — | CN | claimed |
| EP-4547220-A1 | A STABLE ORAL LIQUID COMPOSITION COMPRISING TERBUTALINE & GUAIFENESIN | Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi (TR) | 2025-05-07 | — | — | EP | claimed |
| US-12257371-B2 | SiOx barrier for pharmaceutical package and coating process | SIO2 MEDICAL PRODUCTS, LLC (US) | 2025-03-25 | — | — | US | claimed |
| US-4895719-A | SUSPENSION, ENCAPSULATION, DRUG DELIVERY | LIPOSOME TECHNOLOGY, INC. (US) | 1990-01-23 | — | — | US | claimed |
| EP-0190449-B1 | ADDITIVE-CONTAINING PAINTS | OECE Industrie Chimiche Spa (IT) | 1989-08-09 | — | — | EP | claimed |
| US-4656027-A | ENCAPSULATED DRUGS | ASTRA LAKEMEDEL AKTIEBOLAG (SE) | 1987-04-07 | — | — | US | claimed |
| EP-0111144-B1 | SUSTAINED RELEASE SOLID DOSAGE FORMS HAVING NON-UNIFORM DISTRIBUTION OF ACTIVE INGREDIENT | MERRELL DOW PHARMACEUTICALS INC. (US) | 1986-12-03 | — | — | EP | claimed |
| EP-0189861-A2 | Percutaneous absorption accelerator for ionic water-soluble medicine | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1986-08-06 | — | — | EP | claimed |
| EP-0069075-B1 | PHARMACEUTICAL PREPARATION FOR TREATING GLAUCOMA AND OCULAR HYPERTENSION | DISPERSA AG (CH) | 1985-11-27 | — | — | EP | claimed |
| US-4472436-A | HIGH DENSITY LIPOOROTEIN, TERBUTALINE | NEO-BIONICS, INC. (US) | 1984-09-18 | — | — | US | claimed |
| EP-0043807-B1 | 1-(DIHYDROXYPHENYL)-2-AMINO-ETHANOL DERIVATIVES; PREPARATION, COMPOSITIONS AND INTERMEDIATES | Aktiebolaget Draco (SE) | 1984-05-30 | — | — | EP | claimed |
| EP-0046144-B1 | THERAPEUTICALLY ACTIVE DERIVATIVES OF PHENYLETHANOL AMINES | Aktiebolaget Draco (SE) | 1984-04-11 | — | — | EP | claimed |
| EP-0069097-A2 | Pharmaceutical mixture | Astra Läkemedel Aktiebolag (SE) | 1983-01-05 | — | — | EP | claimed |